Impact of Body Mass Index (BMI) on the Effect of a Lactobacillus Rhamnosus GG (LGG)/Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) Combination on Gut Microbiota (P20-023-19)

This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days (n = 18, P group)...

Full description

Saved in:
Bibliographic Details
Published inCurrent developments in nutrition Vol. 3; no. Supplement_1; p. nzz040.P20-023-19
Main Authors Poutsiaka, Debra, Stern, Lori, Riquelme, Virginia, Hollister, Emily, Cope, Julia, Nasser, Waleed, Dinh, Duy, Nassif, Joy, Thorpe, Cheleste, Kane, Anne, McDermott, Laura, Snydman, David
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2019
Oxford University Press
Subjects
Online AccessGet full text
ISSN2475-2991
2475-2991
DOI10.1093/cdn/nzz040.P20-023-19

Cover

Loading…
Abstract This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group). Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Pfizer Inc.
AbstractList This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group). Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Pfizer Inc.
This exploratory study builds upon an earlier study of probiotic supplementation¹ to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group). Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes². We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Pfizer Inc.
Objectives This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Methods Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group). Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Results Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. Conclusions We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Funding Sources Pfizer Inc.
ObjectivesThis exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI.MethodsHealthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group).Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes.ResultsFollowing P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25.ConclusionsWe observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI.Funding SourcesPfizer Inc.
This exploratory study builds upon an earlier study of probiotic supplementation to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days (  = 18, P group) or did not (  = 7, C group).Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation,  = 0.04 and  = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (  = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422,  = 0.04; K03406,  = 0.06; K02407,  = 0.08; K02397,  = 0.08; K02396,  = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes . We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Pfizer Inc.
ArticleNumber nzz040.P20-023-19
Author Stern, Lori
Poutsiaka, Debra
McDermott, Laura
Cope, Julia
Kane, Anne
Nasser, Waleed
Dinh, Duy
Snydman, David
Hollister, Emily
Thorpe, Cheleste
Riquelme, Virginia
Nassif, Joy
AuthorAffiliation 3 Diversigen, Inc
2 Pfizer Consumer Healthcare
1 Tufts Medical Center
AuthorAffiliation_xml – name: 1 Tufts Medical Center
– name: 2 Pfizer Consumer Healthcare
– name: 3 Diversigen, Inc
Author_xml – sequence: 1
  givenname: Debra
  surname: Poutsiaka
  fullname: Poutsiaka, Debra
  organization: Tufts Medical Center
– sequence: 2
  givenname: Lori
  surname: Stern
  fullname: Stern, Lori
  organization: Pfizer Consumer Healthcare
– sequence: 3
  givenname: Virginia
  surname: Riquelme
  fullname: Riquelme, Virginia
  organization: Diversigen, Inc
– sequence: 4
  givenname: Emily
  surname: Hollister
  fullname: Hollister, Emily
  organization: Diversigen, Inc
– sequence: 5
  givenname: Julia
  surname: Cope
  fullname: Cope, Julia
  organization: Diversigen, Inc
– sequence: 6
  givenname: Waleed
  surname: Nasser
  fullname: Nasser, Waleed
  organization: Diversigen, Inc
– sequence: 7
  givenname: Duy
  surname: Dinh
  fullname: Dinh, Duy
  organization: Diversigen, Inc
– sequence: 8
  givenname: Joy
  surname: Nassif
  fullname: Nassif, Joy
  organization: Diversigen, Inc
– sequence: 9
  givenname: Cheleste
  surname: Thorpe
  fullname: Thorpe, Cheleste
  organization: Tufts Medical Center
– sequence: 10
  givenname: Anne
  surname: Kane
  fullname: Kane, Anne
  organization: Tufts Medical Center
– sequence: 11
  givenname: Laura
  surname: McDermott
  fullname: McDermott, Laura
  organization: Tufts Medical Center
– sequence: 12
  givenname: David
  surname: Snydman
  fullname: Snydman, David
  organization: Tufts Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31225291$$D View this record in MEDLINE/PubMed
BookMark eNqNUltv0zAUjtAQG2M_AWSJl_Yhqy9xEj8wtFYjVOoE4vJsOc4J9UjsEicT3R_j7-EuZYy9DMnyObK_7zvX59GBdRai6CXBpwQLNtOVndmbG5zg048Ux5iymIgn0RFNMh5TIcjBPf8wOvH-CmNMhBApFs-iQ0Yo5VSQo-jXst0o3SNXo7mrtuhSeY-WtoKfaDK_XE6Rs6hfA7qoaxhhCq0CwZVKm6YZPPq0Vq11PnhFgSaropjO5qY21Q7RQ2eGFp1b06rGePR5KP0GtAF_KxJe5vOY0BBqZ6Zo4drSWNWbEDWcYujRpdGdK43rFZr8rXX6Inpaq8bDyd4eR1_fXXxZvI9XH4rl4nwVa5YzcXuTlEEuKkZ4RlOdK1xzKLO0zDmnWV0pUROeJhXJK1byBEoCOgOgoHSK2XF0NupuhrKFSoPtO9XITRcq6rbSKSP__bFmLb-5a5nyLE_SLAhM9gKd-zGA72VrvIamURbc4CVljBOaCryL9foB9MoNnQ3lyVCESATNMQmoV_czukvlz0wDgI-A0DjvO6jvIATL3frIsD5yXB8ZWipDSyURgYdHnhs2j1D2UwiUtyMFwgiuDXTSh-FaDZXpwrrIyplHg755oKAbY41WzXfY_gf_Nzpq70c
ContentType Journal Article
Copyright 2019 American Society for Nutrition.
Copyright © American Society for Nutrition 2019. 2019
Copyright © American Society for Nutrition 2019.
Copyright_xml – notice: 2019 American Society for Nutrition.
– notice: Copyright © American Society for Nutrition 2019. 2019
– notice: Copyright © American Society for Nutrition 2019.
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7S9
L.6
5PM
DOI 10.1093/cdn/nzz040.P20-023-19
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
AGRICOLA
Publicly Available Content Database


PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate Nutrition 2019 Abstracts
EISSN 2475-2991
ExternalDocumentID PMC6578467
31225291
10_1093_cdn_nzz040_P20_023_19
10.1093/cdn/nzz040.P20-023-19
S2475299123151183
Genre Journal Article
GroupedDBID .1-
.FO
0R~
7RV
7X7
8FI
8FJ
AAFWJ
AAHBH
AALRI
AAPXW
AAVAP
AAXUO
AAYWO
ABPTD
ABUWG
ABXVV
ACGFS
ACVFH
ADBBV
ADCNI
ADVLN
AEUPX
AFJKZ
AFKRA
AFPKN
AFPUW
AFRHN
AIGII
AITUG
AJUYK
AKBMS
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMNDL
AMRAJ
AOIJS
APXCP
BAYMD
BCNDV
BENPR
CCPQU
EBS
EJD
EMOBN
FDB
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
IAO
IHR
INH
ITC
KSI
M~E
NAPCQ
O9-
OK1
PHGZM
PHGZT
PIMPY
PPXIY
PUEGO
RPM
UKHRP
Z5R
0SF
6I.
AAFTH
ABDBF
AFULF
BTTYL
ROX
TOX
AAYXX
CITATION
ABEJV
ABGNP
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7S9
L.6
5PM
ID FETCH-LOGICAL-c3839-c383163e89d315726c8a0f5eb76b85527fda9f1564d18d3b54eb1ec7ee2eac603
IEDL.DBID 7X7
ISSN 2475-2991
IngestDate Thu Aug 21 14:07:18 EDT 2025
Fri Jul 11 07:41:56 EDT 2025
Fri Jul 25 09:17:53 EDT 2025
Mon Mar 03 18:06:47 EST 2025
Tue Jul 01 01:04:28 EDT 2025
Mon Jun 30 08:34:46 EDT 2025
Sat Jul 20 16:35:13 EDT 2024
Tue Aug 26 16:34:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Supplement_1
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3839-c383163e89d315726c8a0f5eb76b85527fda9f1564d18d3b54eb1ec7ee2eac603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3169492801?pq-origsite=%requestingapplication%
PMID 31225291
PQID 3169492801
PQPubID 7121353
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6578467
proquest_miscellaneous_2335126900
proquest_journals_3169492801
pubmed_primary_31225291
crossref_primary_10_1093_cdn_nzz040_P20_023_19
oup_primary_10_1093_cdn_nzz040_P20-023-19
elsevier_sciencedirect_doi_10_1093_cdn_nzz040_P20_023_19
elsevier_clinicalkey_doi_10_1093_cdn_nzz040_P20_023_19
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-Jun
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-Jun
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford
PublicationTitle Current developments in nutrition
PublicationTitleAlternate Curr Dev Nutr
PublicationYear 2019
Publisher Elsevier Inc
Oxford University Press
Publisher_xml – name: Elsevier Inc
– name: Oxford University Press
SSID ssj0001999609
Score 2.0696068
Snippet This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on...
ObjectivesThis exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and...
This exploratory study builds upon an earlier study of probiotic supplementation to assess the effects of a probiotic combination (P) of LGG and BB-12 on human...
Objectives This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and...
This exploratory study builds upon an earlier study of probiotic supplementation¹ to assess the effects of a probiotic combination (P) of LGG and BB-12 on...
SourceID pubmedcentral
proquest
pubmed
crossref
oup
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage nzz040.P20-023-19
SubjectTerms Archaea
Bifidobacterium animalis
Body mass index
community structure
feces
Genes
Gut microbiota
intestinal microorganisms
Lactobacillus rhamnosus
metabolome
metagenomics
microbial communities
Microbiota
Nutritional Microbiology
Probiotics
proteome
ribosomal RNA
transcriptome
Title Impact of Body Mass Index (BMI) on the Effect of a Lactobacillus Rhamnosus GG (LGG)/Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) Combination on Gut Microbiota (P20-023-19)
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2475299123151183
https://dx.doi.org/10.1093/cdn/nzz040.P20-023-19
https://www.ncbi.nlm.nih.gov/pubmed/31225291
https://www.proquest.com/docview/3169492801
https://www.proquest.com/docview/2335126900
https://pubmed.ncbi.nlm.nih.gov/PMC6578467
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZge-EFAeOSbVRGQqh5yJqrEz-hBm1Z0TpNE5P6ZjlxokVanbE0D9sf4-9xTi7tihDjpa0aO3bj0-98ts_5TMjnInQzVzFpSeAWFuqXWCmAoCUzPwX-EUjfwUTh-Tk7vfK_L4JFv-BW92GVAya2QK2qDNfIJ57DuM9dANSvtz8tPDUKd1f7IzSek12ULsOQrnARbtZYkM3bfEjc4d4kU3qiHx7Aco8uYN4EDstCjZ2_u6StjLdHxPPP-MlHDunkFXnZM0k67Yb-NXmW6zdkb6phFr28p19oG9vZLprvkV-zNhmSVgWNK3VP50CZ6QyFEuk4ns9MWmkKTJB2WsZYTNIzPIknlVl5c9PU9PJaLnVVw6ckoeOzJDEncVmUCkug3HOzpFNdLlFOkSIY4bH2ed3eBL6JY8txoSl8MylgEMzHW5PAhpNmRedlJwi1knS8eWTmW3J1cvzj26nVH9lgZTDV5e0rMLw84spzgtBlWSTtIsjTkKURir0VSvICBWqUEykvDXzwFXkW5rkLHoDZ3juyoyudfyA0UkWUMT-E-aPrw49P_SxyU6CvoQx9FiiDHA2jJm47ZQ7R7ah7AoZZdMMsoM8C-iwcbhA2jK0Y0k4BKAX4jqcqRuuKPS_p-Mb_VDXBiJ7oX_9MDXI4mJrogaQWG7M3yKf1ZYAA3NeROq-aWrieB7SNcds2yPvOMtcteg4Atsuhdrhls-sCKC--fUWX163MOAMwBze6_-9uHZAXwCF5Fz13SHZWd03-EXjaKh21f8YR2Y2Pzy8uR-1qx2-eqDsb
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pb9MwFLZGd4ALGowfZQOMBKg9ZG2cxIkPCDWwtWVtNU2btJtx4kSLtDqFtELdH8WVf4_nOGlXhBiXXdoqsWM37_l737P9nhF6m_okJpIKSwC3sHT-EisCELRE7EbAPzzh2jpQeDyhg3P3y4V3sYV-1rEweltljYklUMs81nPkHcemzGUEAPXj7JulT43Sq6v1ERpGLY6T5Q9w2YoPw88g33eEHB2efRpY1akCVgzeGCs_gYQkAZOO7fmExoHopl4S-TQKdD6yVAqW6hwq0g6kE3kuwFkS-0lCAKRo14Hn3kPbrgOuTANth4eTk9P1rI72H7qsDhViTieWqqOur2GsHJyApwYm0tJZff5uBDdi7G5Q3T93bN4wgUc76GHFXXHPKNsjtJWox2i3p8Bvny7xe1zuJi2n6XfRr2EZfonzFIe5XOIxkHQ81KkZcSscD9s4Vxi4JzbZk3UxgUf67J9IxNnV1aLAp5diqvICfvX7uDXq99udMEszqUvoBNOLKe6pbKoTOGINf7MEYKooHwJXwtCyCTSlv9oYUC_KzLynbri_mONxZlJQzQVurV9Z-wk6vxNxPkUNlavkOcKBTIOYuj54rMSFPx-5cUAiIMy-8F3qySY6qKXGZyYXCDdr-A4HMXMjZg595tBnbrMmorVseR3oCtDMwVrdVjFYVayYkGE4_1O1DUp0S_-qd9pE-7Wq8Qq6Cr4eaE30ZnUbQEevJAmV5IuCE8cBokhZt9tEz4xmrlp0bDARhEFtf0NnVwV0QvPNOyq7LBObUzAfYLhf_Ltbr9H9wdl4xEfDyfEeegAMlpm9e_uoMf--SF4CS5xHr6qhidHXu0aD3_TbdpU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+Body+Mass+Index+%28BMI%29+on+the+Effect+of+a+Lactobacillus+Rhamnosus+GG+%28LGG%29%2FBifidobacterium+Animalis+Subspecies+Lactis+BB-12+%28BB-12%29+Combination+on+Gut+Microbiota+%28P20-023-19%29&rft.jtitle=Current+developments+in+nutrition&rft.au=Poutsiaka%2C+Debra&rft.au=Stern%2C+Lori&rft.au=Riquelme%2C+Virginia&rft.au=Hollister%2C+Emily&rft.date=2019-06-01&rft.pub=Elsevier+Inc&rft.issn=2475-2991&rft.eissn=2475-2991&rft.volume=3&rft_id=info:doi/10.1093%2Fcdn%2Fnzz040.P20-023-19&rft.externalDocID=S2475299123151183
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2475-2991&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2475-2991&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2475-2991&client=summon